Compare SCLX & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | ACU |
|---|---|---|
| Founded | 2011 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 145.9M |
| IPO Year | N/A | N/A |
| Metric | SCLX | ACU |
|---|---|---|
| Price | $19.15 | $37.07 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 122.8K | 9.4K |
| Earning Date | 11-14-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.45 |
| Revenue | $40,360,000.00 | ★ $194,960,991.00 |
| Revenue This Year | N/A | $3.05 |
| Revenue Next Year | $749.70 | $4.20 |
| P/E Ratio | ★ N/A | $15.13 |
| Revenue Growth | N/A | ★ 2.35 |
| 52 Week Low | $3.60 | $34.35 |
| 52 Week High | $34.27 | $45.25 |
| Indicator | SCLX | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 47.72 |
| Support Level | $18.34 | $36.24 |
| Resistance Level | $20.62 | $38.16 |
| Average True Range (ATR) | 2.22 | 0.85 |
| MACD | -0.02 | 0.21 |
| Stochastic Oscillator | 32.91 | 59.02 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.